Wellspring Financial Advisors LLC Buys Shares of 2,053 Intuitive Surgical, Inc. $ISRG

Wellspring Financial Advisors LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 2,053 shares of the medical equipment provider’s stock, valued at approximately $1,163,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. Draper Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 41.9% during the fourth quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock valued at $2,848,000 after acquiring an additional 1,485 shares during the period. Oppenheimer Asset Management Inc. lifted its holdings in Intuitive Surgical by 29.3% in the fourth quarter. Oppenheimer Asset Management Inc. now owns 71,077 shares of the medical equipment provider’s stock worth $40,255,000 after purchasing an additional 16,119 shares during the period. Procyon Advisors LLC lifted its holdings in Intuitive Surgical by 787.8% in the fourth quarter. Procyon Advisors LLC now owns 4,794 shares of the medical equipment provider’s stock worth $2,715,000 after purchasing an additional 4,254 shares during the period. Vanguard Group Inc. lifted its holdings in Intuitive Surgical by 0.8% in the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider’s stock worth $15,026,776,000 after purchasing an additional 263,828 shares during the period. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in Intuitive Surgical by 22.5% in the third quarter. China Universal Asset Management Co. Ltd. now owns 11,463 shares of the medical equipment provider’s stock worth $5,127,000 after purchasing an additional 2,102 shares during the period. Institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of several research analyst reports. Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective for the company in a report on Wednesday, March 11th. UBS Group cut their price objective on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating on the stock in a report on Tuesday, March 17th. The Goldman Sachs Group set a $558.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, May 27th. Robert W. Baird upped their price objective on shares of Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. Finally, Truist Financial reduced their price objective on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research note on Wednesday, April 15th. Nineteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $573.63.

Insider Activity

In other news, Director Amy L. Ladd sold 500 shares of the company’s stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total value of $236,730.00. Following the transaction, the director owned 239 shares in the company, valued at $113,156.94. This represents a 67.66% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the transaction, the senior vice president owned 6,463 shares in the company, valued at $2,718,014.65. This represents a 46.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 7,144 shares of company stock worth $3,048,782 in the last 90 days. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Trading Down 3.4%

ISRG stock opened at $412.02 on Thursday. Intuitive Surgical, Inc. has a one year low of $396.68 and a one year high of $603.88. The firm has a market capitalization of $145.92 billion, a PE ratio of 49.94, a P/E/G ratio of 3.41 and a beta of 1.46. The firm has a 50-day moving average of $444.91 and a two-hundred day moving average of $497.84.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The company had revenue of $2.77 billion during the quarter, compared to analyst estimates of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.81 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: ISRG was upgraded to a Zacks Rank #2 (Buy), signaling improving earnings expectations and adding a bullish catalyst for the stock.
• Positive Sentiment: Analysts say Intuitive Surgical can use its scale, cost discipline, and growing da Vinci 5 adoption to offset tariff and input-cost pressure, which supports the company’s margin outlook.
• Positive Sentiment: The stock also recently outperformed the broader market, reflecting continued investor confidence in its growth profile. Article: Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts
• Neutral Sentiment: Two executives sold shares under pre-arranged Rule 10b5-1 plans, including EVP Gary Loeb and EVP Mark Brosius. The sales were relatively small and routine, so they may be viewed more as portfolio management than a major red flag.
• Neutral Sentiment: Analyst commentary also noted that ISRG’s fair value estimate was reset lower, which suggests some caution remains despite the company’s long-term growth story.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.